AVEO Pharmaceuticals (AVEO) Climbs 122.81% This Month: How Does it Score?

Wednesday, April 3, 2019 10:16 AM | Brad Spears

AVEO Pharmaceuticals, Inc. (AVEO) stock is higher by more than 122% in the past month. AVEO stock is lower by -55.28% over the last 12 months. The average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AVEO stock a score of 56 out of a possible 100.

That score is primarily influenced by a short-term technical score of 96. AVEO's score also includes a long-term technical score of 44. The fundamental score for AVEO stock is 27. In addition to the average rating from Wall Street analysts, AVEO stock has a mean target price of $1.75. This means analysts expect the stock to climb 37.80% over the next 12 months.

What's Happening with AVEO Stock Today

AVEO Pharmaceuticals, Inc. (AVEO) stock is lower by -19.52% while the S&P 500 is higher by 0.37% as of 10:04 AM on Wednesday, Apr 3. AVEO stock is lower by -$0.31 from the previous closing price of $1.58 on volume of 8,217,784 shares. Over the past year the S&P 500 is up 11.46% while AVEO is lower by -55.28%. AVEO stock lost -$0.04 per share in the over the last 12 months.

Get more analysis and trade ideas on AVEO Pharmaceuticals, Inc. (AVEO) stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

40% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 57% with annual

InvestorsObserver Premium

$ 20.75 $ 12.45 /month
$249 $149.40 billed annually

You May Also Like

Related Articles

Affordable Stocks Trading at New Highs

The Dogs Come up a Little Short in 2019

Cronos Group (CRON) Stock: How Does it Score?

Lipocine (LPCN) Stock: What's Next?

Novus Therapeutics (NVUS) Stock Falls -18.6%: How Does it Score?

What's Next for Cronos Group (CRON) Stock?

Related Companies